MedinCell S.A. logo

MedinCell S.A.

EPA:MEDCL.PA

Overview | Financials
Company Name MedinCell S.A.
Symbol MEDCL.PA
Currency EUR
Price 16.4
Market Cap 477,053,794
Dividend Yield 0%
52-week-range 5.25 - 19
Industry Biotechnology
Sector Healthcare
CEO Mr. Christophe Douat
Website https://www.medincell.com

An error occurred while fetching data.

About MedinCell S.A.

MedinCell S.A. develops various therapeutic solutions. It develops solutions based on BEPO, a technology for long-acting injectable products based on proprietary copolymers and a biocompatible solvent, which solubilizes or suspends the active pharmaceutical ingredients. The company's products in development include mdc-IRM, a subcutaneous injection in Phase III trials for use

Related Stocks

UG Healthcare Corporation Limited logo

UG Healthcare Corporation Limited

8K7.SI

0.13 SGD

DBV Technologies S.A. logo

DBV Technologies S.A.

DBV.PA

2.136 EUR

Cellectis S.A. logo

Cellectis S.A.

ALCLS.PA

2.02 EUR

Amplitude Surgical SA logo

Amplitude Surgical SA

AMPLI.PA

3.06 EUR

Genfit S.A. logo

Genfit S.A.

GNFT.PA

3.87 EUR

OSE Immunotherapeutics SA logo

OSE Immunotherapeutics SA

OSE.PA

6.58 EUR

Novacyt S.A. logo

Novacyt S.A.

ALNOV.PA

0.776 EUR

Nanobiotix S.A. logo

Nanobiotix S.A.

NANO.PA

4.38 EUR

Financials

Numbers are in millions USD

Numbers are in millions USD